Johnson & Johnson (J&J) will buy medical-device maker, Synthes, for $21.3 billion, The Wall Street Journal reports. As per the deal, Synthes shareholders will receive $63.8 in cash in exchange of each share and $118.6 in J&J common stock. The transaction is expected to be completed by the first half of 2012. J&J may fund the acquisition using cash on hand. The merger is expected to close in the first half of next year.
Click here for the story from The Wall Street Journal.
Click here for the additional coverage from Bloomberg.